Showing 1 - 5 results of 5 for search 'Herbert Temmes', query time: 0.02s Refine Results
  1. 1
    ‘That would have been the perfect thing after diagnosis’: development of a digital lifestyle management application in multiple sclerosis

    ‘That would have been the perfect thing after diagnosis’: development of a digital lifestyle management application in multiple sclerosis by Nicole Krause, Karin Riemann-Lorenz, Anne Christin Rahn, Jana Pöttgen, Sascha Köpke, Björn Meyer, Frithjof Thale, Herbert Temmes, Markus van de Loo, Stefan M. Gold, Christoph Heesen

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study

    Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study by Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Löbermann, Melanie Peters, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe Klaus Zettl

    Published 2023-05-01
    Get full text
    Article
  3. 3
    Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study

    Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observ... by Firas Fneish, Niklas Frahm, Melanie Peters, David Ellenberger, Judith Haas, Micha Löbermann, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe K. Zettl

    Published 2023-12-01
    Get full text
    Article
  4. 4
    SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study

    SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study by Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Loebermann, Tina Parciak, Melanie Peters, Dieter Pöhlau, Jeff Rodgers, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Uwe K. Zettl, Rodden M. Middleton

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol

    Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol by Clemens Warnke, Stephanie Stock, Martin Hellmich, Gereon R Fink, Heidrun Golla, Raymond Voltz, Judith Haas, Julia Strupp, Volker Limmroth, Anne Müller, Eckhard Bonmann, Kim Dillen, Thomas Dojan, Solveig Ungeheuer, Petra Schmalz, Angelika Staß, Vanessa Mildenberger, Yasemin Goereci, Veronika Dunkl, Oliver Cornely, Alexander Stahmann, Peter Löcherbach, Lothar Burghaus, Kathrin Gerbershagen, Gereon Nelles, Thomas Joist, Herbert Temmes

    Published 2022-01-01
    Get full text
    Article

Search Tools: